Attract proprietary deal flow that fits your mandate, all on one secure network.
↓
Find and close investment deals before they hit the market.
We are a leading provider of BioTech Solutions in Europe and Asia. Our company has been in the industry for two decades and we collaborate with scientists and universities all over the globe. Now looking for investments from trusted investors.
Connect to CEOWe are looking for investment of up to $10M in our sugar refinery business in Japan. We currently serve the Japanese market but are looking for investment in order to expand to overseas markets. Experience in the industry is preferred.
Connect to CEOWe require equity investment to grow our market share in Asia. Our company boasts an experienced management team & projected EBITDA $85M by year 5. Seeking at least $50M in equity to fund client acquisition.
Connect to CEOOur family-owned company, founded in 1962, is looking for minimum investments of €100K. We are acquiring land for olive plantation, covering the whole value chain. High profit margin projected for a long term investment.
Connect to CEOSet your deal size, industry, and geographical area to suit your investment mandate.
We are international investors raising funds for our venture capital firm. We currently have offices in Singapore and Egypt & top-tier firms as co-investors. We generate a gross IIR of 40%. Seeking investors to further expand our growth.
Connect to CEOOur firm has been around for more than three decades and has a wide portfolio of investments. We’re now looking to invest in businesses active in Fin-Tech, which are in start-up or scale-up phase. Open to both minority and majority investments.
Connect to CEOWe are a US-based athlete-backed venture capital firm at the center of the explosive growth in the online sports industry. We are raising funds for further growth, with a minimum investment of $250K. Expected ROI 22%.
Connect to CEOLooking to raise 2nd round for VC fund with a target of $85M and minimum investment of $1M. 1st VC fund deployed $50M into 19 companies. We’re an AI company serving the international tourism sector with HQ in the USA.
Connect to CEODiversify your investment portfolio by investing in verified businesses.
We’re a US-based sports apparel company with 25+ stores and $40M in revenues, growing 5% annually. I am one of the founders of the company and I am selling up to 15% of the shares I possess. The company is profitable.
Connect to CEOWe’re seeking capital for our online loan service for middle- and high-income customers. Founded in 2009, we reached a revenue of $128M and a 12% EBITDA last year. Looking to sell 10-20% of shares to minority investors.
Connect to CEOI own shares in 10+ businesses in Asia, mainly Japan, China and South-Corea. All kind of companies: retail, healthcare, tech, F&B and more. I own between 1 and 25% of the shares of these companies. Looking to find interested buyers.
Connect to CEOWe develop revolutionary mobile applications for 250+ customers, mainly in Europe but also on other continents. In order to achieve further growth, we’re now looking for investors who are willing to buy 1-5% of our shares.
Connect to CEOBe first to invest in growing industries and innovative companies.
We are currently raising equity to ramp up users’ acquisition and to invest in R&D for our product, a start-up that helps automate routine checks for doctors. We are targeting a $55M investment in the coming years, before IPO in 2023.
Connect to CEORaising $1 M from investors prior to our Series A Capital. We are a fast-growing edutech marketplace for tutors, parents and students, for online education. We are now scaling up and in need of investment to achieve this. HQ is based in Toronto.
Connect to CEOWe are federally licensed for cultivating and producing cannabis products and specialize in medical use markets. We’re seeking investment for innovating our facilities and production techniques. High growth potential.
Connect to CEOOur company focuses mainly on the development of radiation therapies to treat cancer. Our latest method has successfully killed cells and has passed human clinical trials. Now looking to raise capital for further developing and production.
Connect to CEO
+44 20 3318 2640